scholarly journals Socioeconomic Inequalities in Human Immunodeficiency Virus (HIV) Sero-Prevalence among Women in Namibia: Further Analysis of Population-Based Data

2021 ◽  
Vol 18 (17) ◽  
pp. 9397
Author(s):  
Michael Ekholuenetale ◽  
Herbert Onuoha ◽  
Charity Ehimwenma Ekholuenetale ◽  
Amadou Barrow ◽  
Chimezie Igwegbe Nzoputam
Keyword(s):  
Human Immunodeficiency Virus ◽  
Hiv Infection ◽  
Formal Education ◽  
Household Survey ◽  
Population Based ◽  
Socioeconomic Inequalities ◽  
Hiv Prevalence ◽  
High Concentration ◽  
Hiv Prevention Strategies ◽  
Immunodeficiency Virus

Socioeconomic inequality is a major factor to consider in the prevention of human immunodeficiency virus (HIV) transmission. The aim of this study was to investigate socioeconomic inequalities in HIV prevalence among Namibian women. Data from a population-based household survey with multistage-stratified sample of 6501 women were used to examine the link between socioeconomic inequalities and HIV prevalence. The weighted HIV prevalence was 13.2% (95% CI: 12.1–14.3%). The HIV prevalence among the poorest, poorer, middle, richer, and richest households was 21.4%, 19.7%, 16.3%, 11.0%, and 3.7%, respectively. Similarly, 21.2%, 21.7%, 11.8%, and 2.1% HIV prevalence was estimated among women with no formal education and primary, secondary, and higher education, respectively. Women from poor households (Conc. Index = −0.258; SE = 0.017) and those with no formal education (Conc. Index = −0.199; SE = 0.015) had high concentration of HIV infection, respectively. In light of these findings, HIV prevention strategies must be tailored to the specific drivers of transmission in low socioeconomic groups, with special attention paid to the vulnerabilities faced by women and the dynamic and contextual nature of the relationship between socioeconomic status and HIV infection.

scholarly journals Epidemiology of Human Immunodeficiency Virus in the United States

2007 ◽  
Vol 20 (3) ◽  
pp. 478-488 ◽  
Author(s):  
Susan Hariri ◽  
Matthew T. McKenna
Keyword(s):  
United States ◽  
Human Immunodeficiency Virus ◽  
Hiv Infection ◽  
Hiv Transmission ◽  
The United States ◽  
Population Based ◽  
True Incidence ◽  
Immunodeficiency Virus ◽  
Sex With Men ◽  
Fundamental Shift

SUMMARY The human immunodeficiency virus (HIV) epidemic emerged in the early 1980s with HIV infection as a highly lethal disease among men who have sex with men and among frequent recipients of blood product transfusions. Advances in the treatment of HIV infection have resulted in a fundamental shift in its epidemiology, to a potentially chronic and manageable condition. However, challenges in the prevention of this infection remain. In particular, increasing evidence suggests that transmission of drug-resistant virus is becoming more common and that the epidemic is having a profound impact on morbidity and mortality in ethnic and racial minority subgroups in the United States. New population-based data collection systems designed to describe trends in behaviors associated with HIV transmission and better methods for measuring the true incidence of transmission will better elucidate the characteristics of HIV infection in the United States and inform future public health policies.

Human Immunodeficiency Virus Infection and Acute Deep Vein Thromboses

2008 ◽  
Vol 14 (3) ◽  
pp. 352-355 ◽  
Author(s):  
Susan Louw ◽  
Barry F. Jacobson ◽  
Harry Büller
Keyword(s):  
Human Immunodeficiency Virus ◽  
Hiv Infection ◽  
South African ◽  
Hiv Infections ◽  
Hiv Prevalence ◽  
Control Group ◽  
Vein Thrombosis ◽  
Immunodeficiency Virus ◽  
Healthy Control ◽  
Deep Vein

Abnormalities that predispose to a hypercoagulable state with an increased incidence of venous thrombosis have been described in human immunodeficiency virus (HIV) infections and are associated with an increased mortality. A recent systematic review by Klein et al concluded that further studies are essential to elucidate the link between HIV infection and deep vein thrombosis (DVT). We prospectively evaluated 24 consecutive, active people presenting with an acute DVT; 13 consented to HIV testing, revealing an HIV prevalence of 84% (95% confidence interval [CI], 0.65-1.04). In a matched healthy control group, the HIV prevalence was 4% (95% CI, 0.039-0.041). The high HIV prevalence in the DVT group that consented to testing was also significantly higher compared to that in the South African population, estimated to be 10% in 2005. Although the study numbers were low, a statistically significant increased prevalence of HIV infection was found in patients with acute DVTs.

scholarly journals The Prevalence of Human Immunodeficiency Virus Infection among Voluntary Blood Donors in Mainland China: A Systematic Review and Meta-Analysis

2021 ◽  
Author(s):  
Zhan Gao ◽  
Yuhui Li ◽  
Liu Zhiyang ◽  
Yang Huang ◽  
Miao He
Keyword(s):  
Human Immunodeficiency Virus ◽  
Hiv Infection ◽  
Blood Donors ◽  
Meta Analysis ◽  
Mainland China ◽  
Hiv Prevalence ◽  
Residual Risk ◽  
Hiv Screening ◽  
Immunodeficiency Virus ◽  
Epidemiological Characteristics

Abstract BACKGROUND: The epidemic of Human Immunodeficiency Virus (HIV) in China has been increasing. Despite the implementation of screening strategies, there was still the residual risk of transfusion-transmitted HIV. This study investigated the HIV prevalence among voluntary blood donors during the past 24 years in order to characterize the epidemiology of HIV.METHODS: The literature concerning the HIV screening reactive rate and prevalence in Chinese voluntary blood donors were collected through the systematic searching of four electronic databases. After integrating data, following the Preferred Reporting of Items for Systematic Reviews and Meta-Analyses guidelines, data manipulation and statistical analyses were conducted by Stata 12.0. We investigated the trend of HIV prevalence (and 95% CIs) and related epidemiological characteristics among blood donors in mainland China.RESULTS: The results indicated that HIV prevalence was 0.0165% (95% CI, 0.0155%-0.0176%) with a remarkable rise, which varied from 2000 (0.0034%) to 2017 (0.0247%). Importantly, the heterogeneity was found in occupations and Donation frequency. Additionally, the HIV prevalence were significantly higher among male donors than among female donors.CONCLUSIONS: Our results indicated obvious difference between HIV screening reactive rate and HIV prevalence in Chinese blood donors and HIV screening reactive rate cannot reflect reality of HIV infection. In this study, continuous increased trend of HIV prevalence demonstrates extended residual risk of blood transfusion, and the whole society is supposed to pay close attention to HIV infection.

Human Immunodeficiency Virus (HIV) Infection in Children

1987 ◽  
Vol 1 (3) ◽  
pp. 381-395 ◽  
Author(s):  
Beverly Ryan ◽  
Edward Connor ◽  
Anthony Minnefor ◽  
Frank Desposito ◽  
James Oleske
Keyword(s):  
Human Immunodeficiency Virus ◽  
Hiv Infection ◽  
Immunodeficiency Virus

Prevalence of and Risk Factors for Low Free Testosterone Levels in Japanese Men with Well-controlled Human Immunodeficiency Virus Infection

2020 ◽  
Vol 18 (5) ◽  
pp. 381-386
Author(s):  
Yusuke Yoshino ◽  
Ichiro Koga ◽  
Yoshitaka Wakabayashi ◽  
Takatoshi Kitazawa ◽  
Yasuo Ota
Keyword(s):  
Risk Factors ◽  
Human Immunodeficiency Virus ◽  
Standard Deviation ◽  
Hiv Infection ◽  
Free Testosterone ◽  
Serum Levels ◽  
University Hospital ◽  
Rapid Decline ◽  
Total Testosterone ◽  
Immunodeficiency Virus

Background: The change in the prevalence of hypogonadism with age in men with human immunodeficiency virus (HIV) infection is subject to debate. Objective: To address this issue, we diagnosed hypogonadism based on serum levels of free testosterone (fTST) rather than total testosterone which is thought to be an inaccurate indicator. We also determined the relationship between age and fTST levels and identified risk factors for hypogonadism in men with HIV infection. Method: We retrospectively reviewed fTST levels and associated clinical factors in 71 wellcontrolled HIV-infected men who were treated at Teikyo University Hospital between April 2015 and March 2016 and who had data available on serum fTST levels, measured >6 months after starting antiretroviral therapy. fTST was measured using radioimmunoassay on blood samples collected in the morning. Risk factors for hypogonadism were identified using Welch’s t-test and multiple regression analysis. Results: The men had a mean (± standard deviation) age of 47.4 ± 13.6 years, and mean (± standard deviation) serum fTST level of 13.0 ± 6.1 pg/mL. Fifteen (21.1%) men had hypogonadism based on a fTST <8.5 pg/mL. Serum fTST levels significantly decreased with age (−0.216 pg/mL/year). Older age and low hemoglobin levels were identified as risk factors for hypogonadism. Conclusion: The men in the study experienced a more rapid decline in fTST levels with age than men in the general population (−0.161 pg/mL/year). Serum fTST levels in men with HIV infection should be monitored, especially in older men and those with low hemoglobin levels.

Sign in / Sign up

Export Citation Format

Share Document